RELATIVE BIOAVAILABILITY OF TWO FORMULATIONS CONTAINING DAPAGLIFLOZIN 10 MG UNDER FED CONDITION IN A RANDOMIZED CROSSOVER STUDY IN HEALTHY CAUCASIAN SUBJECTS
Sign Up to like & getrecommendations! Published in 2020 at "Farmacia"
DOI: 10.31925/farmacia.2020.1.11
Abstract: The study aimed to evaluate the bioequivalence of a 10 mg dapagliflozin immediate release tablet, developed by Sun Pharmaceutical Industries, India, with the reference product Farxiga (AstraZeneca Pharmaceuticals LP, USA). The bioequivalence was assessed on… read more here.
Keywords: healthy caucasian; fed condition; study; crossover study ... See more keywords